C3orf14 Inhibitors
C3orf14 (Chromosome 3 Open Reading Frame 14) is a gene located on the third chromosome in humans. Like many open reading frame (ORF) genes, C3orf14 is not well characterized in terms of function and biological significance. This lack of information makes C3orf14 a subject of curiosity and investigation in genomic and molecular biology research. The protein encoded by this gene has yet to be thoroughly studied, meaning that its role in cellular processes and pathways remains largely unknown.
Research may eventually uncover the specific functions, interactions, and cellular locations of the C3orf14 protein, shedding light on its contribution to human biology and health. Understanding this protein may also reveal its involvement in any disease processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could inhibit histone deacetylases, possibly influencing the chromatin structure and affecting C3orf14 expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA may inhibit histone deacetylases, altering the chromatin structure around C3orf14 and influencing its expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A might bind to specific DNA sequences, potentially blocking transcription factors from binding and thus affecting C3orf14 expression. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
JQ1 may inhibit the binding of bromodomain proteins to acetylated histones, influencing chromatin structure and gene expression. | ||||||
RG 108 | 48208-26-0 | sc-204235 sc-204235A | 10 mg 50 mg | $131.00 $515.00 | 2 | |
RG108 might inhibit DNA methyltransferases, leading to demethylation and potential alteration of C3orf14 expression. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Although primarily a PARP inhibitor, Olaparib could influence DNA repair pathways and indirectly affect gene expression. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Pladienolide B inhibits the spliceosome, potentially affecting the splicing and maturation of C3orf14 mRNA transcripts. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
Decitabine might act as a DNA methyltransferase inhibitor, leading to demethylation and potential alteration of C3orf14 expression. | ||||||
GSK126 | 1346574-57-9 | sc-490133 sc-490133A sc-490133B | 1 mg 5 mg 10 mg | $92.00 $243.00 $306.00 | ||
GSK126 may inhibit EZH2, a histone methyltransferase, potentially affecting chromatin structure and C3orf14 expression. | ||||||
BIX01294 hydrochloride | 1392399-03-9 | sc-293525 sc-293525A sc-293525B | 1 mg 5 mg 25 mg | $37.00 $112.00 $408.00 | ||
BIX01294 might inhibit G9a histone methyltransferase, potentially influencing chromatin structure and affecting C3orf14 expression. | ||||||